Matches in Wikidata for { <http://www.wikidata.org/entity/Q79401721> ?p ?o ?g. }
Showing items 1 to 63 of
63
with 100 items per page.
- Q79401721 description "article scientifique (publié 2007)" @default.
- Q79401721 description "artikull shkencor i botuar më 01 janar 2007" @default.
- Q79401721 description "artículu científicu espublizáu en xineru de 2007" @default.
- Q79401721 description "im Januar 2007 veröffentlichter wissenschaftlicher Artikel" @default.
- Q79401721 description "scientific article published on 01 January 2007" @default.
- Q79401721 description "wetenschappelijk artikel" @default.
- Q79401721 description "наукова стаття, опублікована в січні 2007" @default.
- Q79401721 name "Neoadjuvant 5-fluorouracil, epirubicin and cyclophosphamide chemotherapy followed by docetaxel in refractory patients with locally advanced breast cancer" @default.
- Q79401721 name "Neoadjuvant 5-fluorouracil, epirubicin and cyclophosphamide chemotherapy followed by docetaxel in refractory patients with locally advanced breast cancer" @default.
- Q79401721 name "Neoadjuvant 5-fluorouracil, epirubicin and cyclophosphamide chemotherapy followed by docetaxel in refractory patients with locally advanced breast cancer" @default.
- Q79401721 type Item @default.
- Q79401721 label "Neoadjuvant 5-fluorouracil, epirubicin and cyclophosphamide chemotherapy followed by docetaxel in refractory patients with locally advanced breast cancer" @default.
- Q79401721 label "Neoadjuvant 5-fluorouracil, epirubicin and cyclophosphamide chemotherapy followed by docetaxel in refractory patients with locally advanced breast cancer" @default.
- Q79401721 label "Neoadjuvant 5-fluorouracil, epirubicin and cyclophosphamide chemotherapy followed by docetaxel in refractory patients with locally advanced breast cancer" @default.
- Q79401721 prefLabel "Neoadjuvant 5-fluorouracil, epirubicin and cyclophosphamide chemotherapy followed by docetaxel in refractory patients with locally advanced breast cancer" @default.
- Q79401721 prefLabel "Neoadjuvant 5-fluorouracil, epirubicin and cyclophosphamide chemotherapy followed by docetaxel in refractory patients with locally advanced breast cancer" @default.
- Q79401721 prefLabel "Neoadjuvant 5-fluorouracil, epirubicin and cyclophosphamide chemotherapy followed by docetaxel in refractory patients with locally advanced breast cancer" @default.
- Q79401721 P1433 Q79401721-FF6544CC-CF70-417C-BF9D-3B6EA951540D @default.
- Q79401721 P1476 Q79401721-F4BF9C8B-96B7-4BED-BFB5-6E5A15454CB9 @default.
- Q79401721 P2093 Q79401721-09D41DB3-195A-4736-8A7D-3D7967C67AC9 @default.
- Q79401721 P2093 Q79401721-0B04321F-455B-4873-925C-D6EEDCA4B228 @default.
- Q79401721 P2093 Q79401721-28CDFBB0-4998-44CC-A6FC-454A3F0EA6D6 @default.
- Q79401721 P2093 Q79401721-5D2F49D1-284C-443B-95AC-773E806A06AA @default.
- Q79401721 P2093 Q79401721-68E742F6-C51E-4FA6-9A9C-EB0D1FF401A1 @default.
- Q79401721 P2093 Q79401721-6AB5E3D1-A900-48DE-8A7E-5EB7B0E2E7D8 @default.
- Q79401721 P2093 Q79401721-9E14CAFE-2220-4BEE-9BD9-C91065849CD3 @default.
- Q79401721 P2093 Q79401721-E17E57CE-8C39-4332-A100-05DBF01E2966 @default.
- Q79401721 P2093 Q79401721-F8A647AB-0A3B-400E-B34F-B831491F6B88 @default.
- Q79401721 P2093 Q79401721-FEE5BB66-3346-4901-BDDA-45D2FF6AC134 @default.
- Q79401721 P304 Q79401721-0A8533E1-A34D-4442-9033-9C2F484B5969 @default.
- Q79401721 P31 Q79401721-D52376D7-8113-468A-ABBC-E357F83F398C @default.
- Q79401721 P356 Q79401721-42962C0D-3AD0-4774-9A23-8CB400ED6910 @default.
- Q79401721 P433 Q79401721-CDF7C4F9-5EC2-434A-9073-7A000CA6F8EE @default.
- Q79401721 P478 Q79401721-6B7BECCE-F089-4F1F-BA32-8C309A0B2FEB @default.
- Q79401721 P577 Q79401721-1AC306DD-E8C6-48E2-A9AB-6172223DE110 @default.
- Q79401721 P698 Q79401721-D6303050-8F3D-42B5-AD41-616A33681E86 @default.
- Q79401721 P921 Q79401721-ADB3CF31-1B31-48CB-AFDC-E7C06D657057 @default.
- Q79401721 P921 Q79401721-B2384D0A-2C19-4896-95B7-F4B538C35779 @default.
- Q79401721 P921 Q79401721-E35683B9-72BA-4FF4-AC5D-3F2A98694BDD @default.
- Q79401721 P356 OR.17.1.253 @default.
- Q79401721 P698 17143506 @default.
- Q79401721 P1433 Q7092098 @default.
- Q79401721 P1476 "Neoadjuvant 5-fluorouracil, epirubicin and cyclophosphamide chemotherapy followed by docetaxel in refractory patients with locally advanced breast cancer" @default.
- Q79401721 P2093 "A Fayaz" @default.
- Q79401721 P2093 "C Lowdell" @default.
- Q79401721 P2093 "C Palmieri" @default.
- Q79401721 P2093 "D Mazhar" @default.
- Q79401721 P2093 "H D Sinnett" @default.
- Q79401721 P2093 "R C Coombes" @default.
- Q79401721 P2093 "R Phillips" @default.
- Q79401721 P2093 "R Ward" @default.
- Q79401721 P2093 "S Shousha" @default.
- Q79401721 P2093 "W Heller" @default.
- Q79401721 P304 "253-259" @default.
- Q79401721 P31 Q13442814 @default.
- Q79401721 P356 "10.3892/OR.17.1.253" @default.
- Q79401721 P433 "1" @default.
- Q79401721 P478 "17" @default.
- Q79401721 P577 "2007-01-01T00:00:00Z" @default.
- Q79401721 P698 "17143506" @default.
- Q79401721 P921 Q238512 @default.
- Q79401721 P921 Q420436 @default.
- Q79401721 P921 Q974135 @default.